Page 145 - Haematologica - Vol. 105 n. 6 - June 2020

Follicular helper T cells in FL
References
1. Harris N, Swerdlow S, Jaffe E, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. 4th ed. Lyon: International Agency for Research on Cancer, 2008.
2. Marafioti T, Copie-Bergman C, Calaminici M, et al. Another look at follicular lym- phoma: immunophenotypic and molecular analyses identify distinct follicular lym- phoma subgroups. Histopathology. 2013;62(6):860-875.
3. Ardeshna KM, Smith P, Norton A, et al. Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet. 2003;362(9383):516-522.
4. Montoto S, Davies AJ, Matthews J, et al. Risk and clinical implications of transforma- tion of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol. 2007;25 (17):2426-2433.
5. Ame-Thomas P, Tarte K. The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity. Semin Cancer Biol. 2014;24:23-32.
6. de Jong D, Koster A, Hagenbeek A, et al. Impact of the tumor microenvironment on prognosis in follicular lymphoma is depend- ent on specific treatment protocols. Haematologica. 2009;94(1):70-77.
7. Farinha P, Al-Tourah A, Gill K, Klasa R, Connors JM, Gascoyne RD. The architectur- al pattern of FOXP3-positive T-cells in follic- ular lymphoma is an independent predictor of survival and histologic transformation. Blood. 2010;115(2):289-295.
8. Farinha P, Masoudi H, Skinnider BF, et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of sur- vival in follicular lymphoma (FL). Blood. 2005;106(6):2169-2174.
9. Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351(21): 2159-2169.
10. Glas AM, Knoops L, Delahaye L, et al. Gene- expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol. 2007;25(4):390-398.
11. Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM. Intratumoral CD4+CD25+ regu- latory T-cell-mediated suppression of infil- trating CD4+ T-cells in B-cell non-Hodgkin lymphoma. Blood. 2006;107(9):3639-3646.
12. Kiaii S, Clear AJ, Ramsay AG, et al. Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transforma- tion. J Clin Oncol. 2013;31(21):2654-2661.
13. Lee AM, Clear AJ, Calaminici M, et al. Number of CD4+ cells and location of fork- head box protein P3-positive cells in diag- nostic follicular lymphoma tissue microar- rays correlates with outcome. J Clin Oncol. 2006;24(31):5052-5059.
14. Wahlin BE, Aggarwal M, Montes-Moreno S, et al. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulato-
ry, cytotoxic, and helper T-cells and macrophages. Clin Cancer Res. 2010;16(2):637-650.
15. Carreras J, Lopez-Guillermo A, Roncador G, et al. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol. 2009;27(9):1470-1476.
16. Richendollar BG, Pohlman B, Elson P, Hsi ED. Follicular programmed death 1-positive lymphocytes in the tumor microenviron- ment are an independent prognostic factor in follicular lymphoma. Hum Pathol. 2011;42(4):552-557.
17. Rolf J, Bell SE, Kovesdi D, et al. Phosphoinositide 3-kinase activity in T-cells regulates the magnitude of the germinal cen- ter reaction. J Immunol. 2010;185(7):4042- 4052.
18. King C. New insights into the differentiation and function of T follicular helper cells. Nat Rev Immunol. 2009;9(11):757-766.
19. Crotty S. T follicular helper cell differentia- tion, function, and roles in disease. Immunity. 2014;41(4):529-542.
20. Linterman MA, Liston A, Vinuesa CG. T-fol- licular helper cell differentiation and the co- option of this pathway by non-helper cells. Immunol Rev. 2012;247(1):143-159.
21. Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. Follicular helper T-cells: lineage and location. Immunity. 2009;30(3):324-335.
22. Yu D, Rao S, Tsai LM, et al. The transcrip- tional repressor BCL6 directs T follicular helper cell lineage commitment. Immunity. 2009;31(3):457-468.
23. Allen CD, Okada T, Cyster JG. Germinal- center organization and cellular dynamics. Immunity. 2007;27(2):190-202.
24. Pangault C, Ame-Thomas P, Ruminy P, et al. Follicular lymphoma cell niche: identifica- tion of a preeminent IL-4-dependent T(FH)- B cell axis. Leukemia. 2010;24(12):2080- 2089.
25. Ame-Thomas P, Le Priol J, Yssel H, et al. Characterization of intratumoral follicular helper T-cells in follicular lymphoma: role in the survival of malignant B cells. Leukemia. 2012;26(5):1053-1063.
with relapsed follicular lymphoma: a single group, open-label, phase 2 trial. Lancet Oncol. 2014;15(1):69-77.
32. Gopal AK, Kahl BS, de Vos S, et al. PI3Kdelta inhibition by idelalisib in patients with relapsed indolent lymphoma. N Engl J Med. 2014;370(11):1008-1018.
33. Robins HS, Campregher PV, Srivastava SK, et al. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T- cells. Blood. 2009;114(19):4099-4107.
34. Yousfi Monod M, Giudicelli V, Chaume D, Lefranc MP. IMGT/Junction Analysis: the first tool for the analysis of the immunoglobulin and T-cell receptor com- plex V-J and V-D-J JUNCTIONs. Bioinformatics. 2004;20 Suppl 1:i379-385.
35. Haynes NM, Allen CDC, Lesley R, Ansel KM, Killeen N, Cyster JG. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1 high germinal center-associated sub- population. J Immunol. 2007;179(8):5099- 5108.
36. Andorsky DJ, Yamada RE, Said J, Pinkus GS, Betting DJ, Timmerman JM. Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T-cells. Clin Cancer Res. 2011;17(13):4232-4424.
37. Kupfer A, Kupfer H. Imaging immune cell interactions and functions: SMACs and the Immunological Synapse. Semin Immunol. 2003;15(6):295-300.
38. Sherwood AM, Emerson RO, Scherer D, et al. Tumor-infiltrating lymphocytes in col- orectal tumors display a diversity of T-cell receptor sequences that differ from the T- cells in adjacent mucosal tissue. Cancer Immunol Immunother. 2013;62(9):1453- 1461.
39. Nazarov VI, Pogorelyy MV, Komech EA, et al. TcR: an R package for T-cell receptor repertoire advanced data analysis. BMC Bioinformatics. 2015;16:175.
40. Myklebust JH, Irish JM, Brody J, et al. High PD-1 expression and suppressed cytokine signaling distinguish T-cells infiltrating follic- ular lymphoma tumors from peripheral T- cells. Blood. 2013;121(8):1367-1376.
41. Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol. 2012;30:429-
26. Yang ZZ, Grote DM, Ziesmer SC, Xiu B,
Novak AJ, Ansell SM. PD-1 expression 457.
defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival. Blood Cancer J. 2015;5:e281.
27. Ame-Thomas P, Hoeller S, Artchounin C, et al. CD10 delineates a subset of human IL-4 producing follicular helper T-cells involved in the survival of follicular lymphoma B cells. Blood. 2015;125(15):2381-2385.
28. Pandey S, Mourcin F, Marchand T, et al. IL- 4/CXCL12 loop is a key regulator of lym- phoid stroma function in follicular lym- phoma. Blood. 2017;129(18):2507-2518.
29. Ansell SM, Lesokhin AM, Borrello I, et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med. 2015;372(4):311-319.
30. Hawkes EA, Grigg A, Chong G. Programmed cell death-1 inhibition in lym- phoma. Lancet Oncol. 2015;16(5):e234-245.
31. Westin JR, Chu F, Zhang M, et al. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients
42. Ramsay AG, Clear AJ, Kelly G, et al. Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunothera- py. Blood. 2009;114(21):4713-4720.
43. Barcia C, Thomas CE, Curtin JF, et al. In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain. J Exp Med. 2006;203(9):2095-2107.
44. Pasqualucci L, Bhagat G, Jankovic M, et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet. 2008;40 (1):108-112.
45. Pasqualucci L, Khiabanian H, Fangazio M, et al. Genetics of follicular lymphoma transfor- mation. Cell Rep. 2014;6(1):130-140.
46. Best K, Oakes T, Heather JM, Shawe-Taylor J, Chain B. Computational analysis of sto- chastic heterogeneity in PCR amplification efficiency revealed by single molecule bar- coding. Sci Rep. 2015;5:14629.
haematologica | 2020; 105(6)
1603